Katie Palen

863 total citations
20 papers, 665 citations indexed

About

Katie Palen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Katie Palen has authored 20 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Katie Palen's work include CAR-T cell therapy research (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (4 papers). Katie Palen is often cited by papers focused on CAR-T cell therapy research (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (4 papers). Katie Palen collaborates with scholars based in United States and China. Katie Palen's co-authors include Bryon D. Johnson, Jill A. Gershan, Michael B. Dwinell, Laura McOlash, Qiuhui Yang, Bryan Hunt, Douglas B. Evans, Susan Tsai, Christine Duris and Michael A. James and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Katie Palen

19 papers receiving 659 citations

Peers

Countries citing papers authored by Katie Palen

Since Specialization

Citations

This map shows the geographic impact of Katie Palen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Palen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Palen more than expected).

Fields of papers citing papers by Katie Palen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Palen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Palen. The network helps show where Katie Palen may publish in the future.

Co-authorship network of co-authors of Katie Palen

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Palen. A scholar is included among the top collaborators of Katie Palen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Palen. Katie Palen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma 2025 ·Journal of Clinical Oncology ·Nirav N. Shah, (unknown), Bryon D. Johnson, Anikó Szabó, Fateeha Furqan, (unknown), Dina Schneider, Mauricio Vargas‐Cortes, (unknown), Michael B. Dwinell, Katie Palen, Walter Longo, Peiman Hematti, Anthony E. Zamora, Parameswaran Hari, (unknown), Ashley M. Cunningham, Mehdi Hamadani, Timothy S. Fenske	2
2	Combination of Pirtobrutinib and Lentiviral Transduced Bispecific Anti-CD20/CD19 (LV20 .19) CAR T-Cell Therapy to Improve Outcomes in Patients With Relapsed/Refractory Lymphoma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Fateeha Furqan, Katie Palen, Bryon D. Johnson, (unknown), (unknown), Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah	0
3	Phase 1 Trial of LV20.19 CAR T-Cells for Relapsed, Refractory CLL and Richter's Transformation 2024 ·Transplantation and Cellular Therapy ·Nirav N. Shah, Ehab Atallah, Sameem Abedin, Guru Subramanian Guru Murthy, Lyndsey Runaas, Laura C. Michaelis, Walter Longo, Fateeha Furqan, (unknown), Anikó Szabó, (unknown), Dina Schneider, Katie Palen, Bryon D. Johnson, Peiman Hematti, Timothy S. Fenske, Mehdi Hamadani	1
4	Cancer chemoprevention with PV-1, a novel Prunella vulgaris-containing herbal mixture that remodels the tumor immune microenvironment in mice 2023 ·Frontiers in Immunology ·Qi Zhang, Xu Chen, Katie Palen, Bryon D. Johnson, (unknown), Donghai Xiong, Jing Pan, Ming Hu, Yian Wang, Ming You	7
5	Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention 2023 ·npj Precision Oncology ·(unknown), (unknown), Donghai Xiong, Katie Palen, Bryon D. Johnson, Ronald A. Lubet, Robert H. Shoemaker, Jeffrey E. Green, Romaine I. Fernando, Shizuko Sei, Ming You, Yian Wang	11
6	Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM) 2023 ·Blood ·Binod Dhakal, Meera Mohan, (unknown), Katie Palen, Anikó Szabó, (unknown), (unknown), Susan Bal, Bryon D. Johnson, Marcelo C. Pasquini, Anita D’Souza, Parameswaran Hari, Luciano J. Costa	1
7	Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention 2023 ·Frontiers in Immunology ·Jing Pan, Donghai Xiong, Qi Zhang, Katie Palen, Robert H. Shoemaker, Bryon D. Johnson, Shizuko Sei, Yian Wang, Ming You	3
8	Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA 2021 ·Communications Biology ·Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, (unknown), Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You	23
9	Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? 2021 ·Cytotherapy ·Katie Palen, Joanna Zurko, Bryon D. Johnson, Parameswaran Hari, Nirav N. Shah	15
10	Successful Manufacturing of CAR T-Cells with Small Volume Peripheral Blood from Healthy Donors Using the Clinimacs Prodigy Device 2020 ·Blood ·Katie Palen, Parameswaran Hari, Nirav N. Shah, Bryon D. Johnson	1
11	Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator 2019 ·EBioMedicine ·Jing Pan, Qi Zhang, Katie Palen, Li Wang, (unknown), Bryon D. Johnson, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Ming You	49
12	STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models 2019 ·Journal for ImmunoTherapy of Cancer ·Weiqing Jing, Donna McAllister, (unknown), Katie Palen, Matthew J. Riese, Jill A. Gershan, Bryon D. Johnson, Michael B. Dwinell	153
13	Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models 2018 ·BMC Cancer ·Susan Tsai, Laura McOlash, Katie Palen, Bryon D. Johnson, Christine Duris, Qiuhui Yang, Michael B. Dwinell, Bryan Hunt, Douglas B. Evans, Jill A. Gershan, Michael A. James	318
14	Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy 2018 ·Journal of Pediatric Hematology/Oncology ·Katie Palen, Monica S. Thakar, Bryon D. Johnson, Jill A. Gershan	3
15	A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis 2018 ·Cancer Epidemiology Biomarkers & Prevention ·Susan Tsai, Laura McOlash, Shuang Jia, Jian Zhang, Pippa Simpson, Mary L. Kaldunski, Mohammed Aldakkak, (unknown), Katie Palen, Michael B. Dwinell, Bryon D. Johnson, Alexander C. Mackinnon, Martin J. Hessner, Jill A. Gershan	2
16	T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia 2017 ·Cancer Research ·Weiqing Jing, Jill A. Gershan, Sandra Holzhauer, James J. Weber, Katie Palen, Laura McOlash, Kirthi Pulakanti, (unknown), Sridhar Rao, Bryon D. Johnson, Matthew J. Riese	17
17	Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice 2017 ·Journal for ImmunoTherapy of Cancer ·Weiqing Jing, Jill A. Gershan, Grace C. Blitzer, Katie Palen, James J. Weber, Laura McOlash, Matthew J. Riese, Bryon D. Johnson	29
18	E-cadherin re-expression showsin vivoevidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells 2016 ·Oncotarget ·Katie Palen, James J. Weber, Michael B. Dwinell, Bryon D. Johnson, Ramani Ramchandran, Jill A. Gershan	20
19	Separation and Characterization of Epithelial and Mesenchymal-like Murine Mammary Tumor Cells Reveals Epithelial Cell Differentiation Plasticity and Enhanced Tumorigenicity of Epithelial-enriched Tumor Cells 2012 ·Cancer Microenvironment ·Katie Palen, Weiqing Jing, James J. Weber, (unknown), Andrew M. Chan, Bryon D. Johnson, Jill A. Gershan	5
20	Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data 2010 ·Cancer Science ·M. Eric Kohler, Bryon D. Johnson, Katie Palen, Qingrong Chen, Javed Khan, Rimas J. Orentas	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact